| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.97 | 0.002 | 0.97 | Aldehyde oxidase inhibitor | 0.198 0.106 CID_154699546 | ||
| 0.969 | 0.004 | 0.969 | Analgesic | 0.673 0.016 CID_154699546 | ||
| 0.93 | 0.002 | 0.93 | Analgesic, opioid | 0.157 0.014 CID_154699546 | ||
| 0.861 | 0.004 | 0.861 | Spasmolytic | 0.483 0.025 CID_154699546 | ||
| 0.776 | 0.003 | 0.776 | P-glycoprotein inhibitor | 0.142 0.129 CID_154699546 | ||
| 0.738 | 0.005 | 0.738 | Hypoglycemic | |||
| 0.674 | 0.009 | 0.756 | 5 Hydroxytryptamine release stimulant | 0.756 0.005 CID_154699546 | CID_154699546 | |
| 0.655 | 0.005 | 0.655 | Potassium channel (Voltage-sensitive) blocker | 0.502 0.014 CID_154699546 | ||
| 0.646 | 0.004 | 0.646 | Glutamate receptor antagonist | |||
| 0.639 | 0.006 | 0.639 | HERG channel blocker | 0.515 0.014 CID_154699546 | ||
| 0.615 | 0.005 | 0.615 | Psychostimulant | 0.582 0.006 CID_154699546 | ||
| 0.557 | 0.003 | 0.557 | Opioid agonist | 0.064 0.026 CID_154699546 | ||
| 0.557 | 0.003 | 0.557 | Opioid mu receptor agonist | 0.06 0.023 CID_154699546 | ||
| 0.555 | 0.004 | 0.555 | Opioid antagonist | 0.137 0.03 CID_154699546 | ||
| 0.546 | 0.004 | 0.546 | Cholinergic antagonist | 0.354 0.01 CID_154699546 | ||
| 0.54 | 0.004 | 0.54 | Opioid mu receptor antagonist | 0.096 0.033 CID_154699546 | ||
| 0.537 | 0.004 | 0.537 | Acetylcholine antagonist | 0.344 0.01 CID_154699546 | ||
| 0.498 | 0.011 | 0.513 | Potassium channel blocker | 0.513 0.01 CID_154699546 | CID_154699546 | |
| 0.454 | 0.004 | 0.454 | Acetylcholine nicotinic antagonist | 0.272 0.008 CID_154699546 | ||
| 0.396 | 0.004 | 0.396 | Opioid kappa receptor antagonist | 0.165 0.014 CID_154699546 | ||
| 0.335 | 0.004 | 0.335 | Neuronal nicotinic receptor antagonist | 0.191 0.009 CID_154699546 | ||
| 0.353 | 0.025 | 0.362 | 5 Hydroxytryptamine uptake stimulant | 0.362 0.022 CID_154699546 | CID_154699546 | |
| 0.318 | 0.005 | 0.318 | NMDA receptor antagonist | |||
| 0.291 | 0.005 | 0.291 | Opioid delta receptor antagonist | 0.092 0.032 CID_154699546 | ||
| 0.288 | 0.014 | 0.288 | Anesthetic local | 0.267 0.017 CID_154699546 | ||
| 0.278 | 0.004 | 0.278 | Opioid delta receptor agonist | 0.034 0.027 CID_154699546 | ||
| 0.258 | 0.047 | 0.466 | Anesthetic general | 0.466 0.01 CID_154699546 | CID_154699546 | |
| 0.347 | 0.148 | 0.378 | Caspase 9 stimulant | 0.378 0.125 CID_154699546 | CID_154699546 | |
| 0.255 | 0.064 | 0.384 | Tyrosine 3 hydroxylase inhibitor | 0.384 0.01 CID_154699546 | CID_154699546 | |
| 0.327 | 0.137 | 0.327 | 5 Hydroxytryptamine release inhibitor | |||
| 0.208 | 0.022 | 0.272 | Acetylcholine muscarinic antagonist | 0.272 0.012 CID_154699546 | CID_154699546 | |
| 0.177 | 0.005 | 0.177 | Androgen agonist | 0.109 0.012 CID_154699546 | ||
| 0.272 | 0.113 | 0.272 | Vasodilator, coronary | 0.269 0.115 CID_154699546 | ||
| 0.207 | 0.051 | 0.207 | 5 Hydroxytryptamine 3E antagonist | 0.207 0.052 CID_154699546 | ||
| 0.28 | 0.13 | 0.389 | GABA C receptor rho-3 antagonist | 0.389 0.066 CID_154699546 | CID_154699546 | |
| 0.172 | 0.033 | 0.172 | Cathepsin H inhibitor | |||
| 0.162 | 0.026 | 0.162 | Falcipain inhibitor | |||
| 0.166 | 0.03 | 0.166 | Falcipain 3 inhibitor | 0.089 0.082 CID_154699546 | ||
| 0.184 | 0.049 | 0.184 | Arachidonic acid antagonist | 0.138 0.102 CID_154699546 | ||
| 0.158 | 0.025 | 0.158 | Falcipain 2 inhibitor | |||
| 0.271 | 0.14 | 0.271 | Histamine release inhibitor | |||
| 0.219 | 0.095 | 0.256 | DNA synthesis inhibitor | 0.256 0.063 CID_154699546 | CID_154699546 | |
| 0.31 | 0.199 | 0.326 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.326 0.179 CID_154699546 | CID_154699546 | |
| 0.169 | 0.059 | 0.33 | Acetylcholine M1 receptor antagonist | 0.33 0.01 CID_154699546 | CID_154699546 | |
| 0.157 | 0.054 | 0.157 | Neurotrophic factor | 0.136 0.073 CID_154699546 | ||
| 0.175 | 0.076 | 0.195 | Lipocortins synthesis antagonist | 0.195 0.06 CID_154699546 | CID_154699546 | |
| 0.15 | 0.054 | 0.151 | Nav1.6 sodium channel blocker | 0.151 0.053 CID_154699546 | CID_154699546 | |
| 0.213 | 0.129 | 0.258 | Gastrin inhibitor | 0.258 0.071 CID_154699546 | CID_154699546 | |
| 0.167 | 0.084 | 0.167 | Succinate dehydrogenase inhibitor | |||
| 0.118 | 0.036 | 0.132 | Calcium antagonist | 0.132 0.029 CID_154699546 | CID_154699546 | |
| 0.14 | 0.061 | 0.14 | Alpha-N-acetylglucosaminidase inhibitor | 0.102 0.099 CID_154699546 | ||
| 0.142 | 0.066 | 0.147 | Ca2+-transporting ATPase inhibitor | 0.147 0.052 CID_154699546 | CID_154699546 | |
| 0.1 | 0.024 | 0.1 | Estrogen-related receptor beta agonist | 0.085 0.051 CID_154699546 | ||
| 0.221 | 0.147 | 0.266 | Cholesterol antagonist | 0.266 0.114 CID_154699546 | CID_154699546 | |
| 0.123 | 0.051 | 0.123 | Aminopeptidase B inhibitor | |||
| 0.224 | 0.153 | 0.224 | Apoptosis antagonist | |||
| 0.194 | 0.124 | 0.194 | Superoxide dismutase inhibitor | |||
| 0.11 | 0.046 | 0.183 | Prolactin inhibitor | 0.183 0.012 CID_154699546 | CID_154699546 | |
| 0.101 | 0.042 | 0.101 | Glutamate release inhibitor | |||
| 0.108 | 0.051 | 0.11 | Sphingomyelinase inhibitor | 0.11 0.049 CID_154699546 | CID_154699546 | |
| 0.078 | 0.021 | 0.078 | Acetyl-CoA transferase inhibitor | |||
| 0.191 | 0.136 | 0.191 | Neuropeptide Y2 antagonist | |||
| 0.116 | 0.062 | 0.128 | Photosensitizer | 0.128 0.048 CID_154699546 | CID_154699546 | |
| 0.108 | 0.056 | 0.108 | Adenylate kinase inhibitor | |||
| 0.069 | 0.018 | 0.175 | Nicotinic alpha3beta2 receptor antagonist | 0.175 0.003 CID_154699546 | CID_154699546 | |
| 0.076 | 0.026 | 0.076 | Caspase 9 inhibitor | |||
| 0.117 | 0.068 | 0.142 | Calcium channel N-type blocker | 0.142 0.043 CID_154699546 | CID_154699546 | |
| 0.136 | 0.089 | 0.136 | Adenylate cyclase stimulant | |||
| 0.211 | 0.164 | 0.34 | Vasodilator, peripheral | 0.34 0.078 CID_154699546 | CID_154699546 | |
| 0.103 | 0.058 | 0.112 | Anabolic | 0.112 0.048 CID_154699546 | CID_154699546 | |
| 0.123 | 0.08 | 0.123 | Vanilloid 1 agonist | 0.121 0.085 CID_154699546 | ||
| 0.07 | 0.027 | 0.07 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.112 | 0.07 | 0.129 | Microtubule formation inhibitor | 0.129 0.052 CID_154699546 | CID_154699546 | |
| 0.049 | 0.008 | 0.049 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.098 | 0.056 | 0.098 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.082 | 0.041 | 0.082 | Aminopeptidase I inhibitor | |||
| 0.064 | 0.025 | 0.064 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.173 | 0.137 | 0.173 | Immunostimulant | |||
| 0.051 | 0.017 | 0.051 | G protein-coupled receptor agonist | |||
| 0.16 | 0.126 | 0.16 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.102 | 0.069 | 0.128 | Ferrochelatase inhibitor | 0.128 0.048 CID_154699546 | CID_154699546 | |
| 0.035 | 0.006 | 0.035 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.112 | 0.084 | 0.173 | Nav1.3 sodium channel blocker | 0.173 0.035 CID_154699546 | CID_154699546 | |
| 0.194 | 0.166 | 0.201 | Insulysin inhibitor | 0.201 0.155 CID_154699546 | CID_154699546 | |
| 0.076 | 0.049 | 0.076 | Glutamate dehydrogenase inhibitor | |||
| 0.115 | 0.089 | 0.185 | Nav1.2 sodium channel blocker | 0.185 0.04 CID_154699546 | CID_154699546 | |
| 0.075 | 0.05 | 0.085 | Vanilloid 4 agonist | 0.085 0.032 CID_154699546 | CID_154699546 | |
| 0.103 | 0.08 | 0.148 | Acetylcholine release stimulant | 0.148 0.018 CID_154699546 | CID_154699546 | |
| 0.062 | 0.038 | 0.062 | Cathepsin E inhibitor | |||
| 0.033 | 0.011 | 0.033 | Estrogen-related receptor gamma antagonist | |||
| 0.092 | 0.069 | 0.092 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.17 | 0.148 | 0.17 | Calpain inhibitor | |||
| 0.091 | 0.07 | 0.091 | Creatine kinase inhibitor | |||
| 0.088 | 0.067 | 0.088 | Uric acid excretion stimulant | |||
| 0.058 | 0.038 | 0.058 | Argininosuccinate synthase inhibitor | |||
| 0.038 | 0.018 | 0.038 | Histone deacetylase 4 inhibitor | |||
| 0.034 | 0.018 | 0.034 | Peptide deformylase inhibitor | |||
| 0.039 | 0.024 | 0.084 | Nicotinic receptor beta4 subunit antagonist | 0.084 0.008 CID_154699546 | CID_154699546 | |
| 0.035 | 0.022 | 0.035 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.071 | 0.058 | 0.088 | CYP2A6 inhibitor | 0.088 0.042 CID_154699546 | CID_154699546 | |
| 0.082 | 0.07 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.088 | 0.076 | 0.088 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.034 | 0.023 | 0.034 | Histone deacetylase 2 inhibitor | |||
| 0.045 | 0.035 | 0.045 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.03 | 0.02 | 0.03 | Histone deacetylase 10 inhibitor | |||
| 0.064 | 0.055 | 0.064 | Elastase 1 inhibitor | |||
| 0.139 | 0.13 | 0.139 | Phospholipase C inhibitor | |||
| 0.06 | 0.052 | 0.06 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.067 | 0.059 | 0.067 | Phospholipase D inhibitor | |||
| 0.022 | 0.014 | 0.022 | Vitamin D receptor antagonist | |||
| 0.038 | 0.03 | 0.038 | Cathepsin L2 inhibitor | |||
| 0.068 | 0.06 | 0.306 | Acetylcholine M4 receptor antagonist | 0.306 0.004 CID_154699546 | CID_154699546 | |
| 0.025 | 0.018 | 0.025 | Vanilloid 2 agonist | |||
| 0.055 | 0.048 | 0.137 | Acetylcholine M3 receptor antagonist | 0.137 0.012 CID_154699546 | CID_154699546 | |
| 0.039 | 0.034 | 0.039 | Kainate receptor agonist | |||
| 0.049 | 0.044 | 0.049 | Human rhinovirus A protease inhibitor | |||
| 0.161 | 0.157 | 0.268 | Interleukin agonist | 0.268 0.066 CID_154699546 | CID_154699546 | |
| 0.026 | 0.023 | 0.039 | Nicotinic alpha4beta2 receptor agonist | 0.039 0.009 CID_154699546 | CID_154699546 | |
| 0.022 | 0.019 | 0.022 | Histone deacetylase 3 inhibitor | |||
| 0.027 | 0.025 | 0.027 | Histone deacetylase class IV inhibitor | |||
| 0.027 | 0.025 | 0.027 | Histone deacetylase 11 inhibitor | |||
| 0.025 | 0.024 | 0.025 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.092 | 0.091 | 0.127 | GABA C receptor antagonist | 0.127 0.046 CID_154699546 | CID_154699546 | |
| 0.063 | 0.062 | 0.063 | Catalase inhibitor | |||
| 0.122 | 0.122 | 0.162 | Pregnane X receptor agonist | 0.162 0.034 CID_154699546 | CID_154699546 | |
| 0.027 | 0.04 | 0.037 | 5-Alpha-reductase inhibitor | 0.037 0.026 CID_154699546 | CID_154699546 | |
| 0.058 | 0.073 | 0.066 | Na+ K+ transporting ATPase inhibitor | 0.066 0.064 CID_154699546 | CID_154699546 | |
| 0.25 | 0.266 | 0.37 | Antiinflammatory | 0.37 0.159 CID_154699546 | CID_154699546 | |
| 0.045 | 0.061 | 0.167 | Acetylcholine M2 receptor antagonist | 0.167 0.009 CID_154699546 | CID_154699546 | |
| 0.1 | 0.117 | 0.261 | Calcium channel blocker | 0.261 0.015 CID_154699546 | CID_154699546 | |
| 0.033 | 0.051 | 0.098 | Glycine transporter inhibitor | 0.098 0.012 CID_154699546 | CID_154699546 | |
| 0.057 | 0.074 | 0.08 | Glutamate (mGluR7) antagonist | 0.08 0.028 CID_154699546 | CID_154699546 | |
| 0.136 | 0.161 | 0.158 | Neurotrophic factor enhancer | 0.158 0.126 CID_154699546 | CID_154699546 | |
| 0.01 | 0.037 | 0.019 | Nicotinic alpha4 receptor agonist | 0.019 0.008 CID_154699546 | CID_154699546 | |
| 0.047 | 0.074 | 0.057 | Sphingosine kinase inhibitor | 0.057 0.045 CID_154699546 | CID_154699546 | |
| 0.062 | 0.093 | 0.098 | Glycine receptor antagonist | 0.098 0.034 CID_154699546 | CID_154699546 | |
| 0.084 | 0.116 | 0.227 | Calcium channel (voltage-sensitive) blocker | 0.227 0.013 CID_154699546 | CID_154699546 | |
| 0.026 | 0.062 | 0.038 | Membrane dipeptidase inhibitor | 0.038 0.03 CID_154699546 | CID_154699546 | |
| 0.037 | 0.076 | 0.058 | HCV NS3/NS4A protease inhibitor | 0.058 0.023 CID_154699546 | CID_154699546 | |
| 0.029 | 0.069 | 0.121 | Nicotinic receptor alpha3 subunit antagonist | 0.121 0.008 CID_154699546 | CID_154699546 | |
| 0.027 | 0.068 | 0.054 | Guanylate cyclase inhibitor | 0.054 0.018 CID_154699546 | CID_154699546 | |
| 0.023 | 0.066 | 0.158 | Sigma receptor antagonist | 0.158 0.011 CID_154699546 | CID_154699546 | |
| 0.051 | 0.096 | 0.127 | Calcium channel L-type blocker | 0.127 0.014 CID_154699546 | CID_154699546 | |
| 0.007 | 0.052 | 0.028 | NMDA receptor phencyclidine site antagonist | 0.028 0.005 CID_154699546 | CID_154699546 | |
| 0.109 | 0.154 | 0.162 | GABA C receptor rho-2 antagonist | 0.162 0.059 CID_154699546 | CID_154699546 | |
| 0.147 | 0.195 | 0.318 | 5 Hydroxytryptamine 1E antagonist | 0.318 0.02 CID_154699546 | CID_154699546 | |
| 0.054 | 0.104 | 0.071 | Glycine receptor agonist | 0.071 0.052 CID_154699546 | CID_154699546 | |
| 0.071 | 0.122 | 0.102 | GABA C receptor rho-1 antagonist | 0.102 0.06 CID_154699546 | CID_154699546 | |
| 0.037 | 0.091 | 0.169 | Acetylcholine M5 receptor antagonist | 0.169 0.006 CID_154699546 | CID_154699546 | |
| 0.032 | 0.086 | 0.233 | Dopamine uptake inhibitor | 0.233 0.005 CID_154699546 | CID_154699546 | |
| 0.066 | 0.127 | 0.094 | GABA C receptor agonist | 0.094 0.074 CID_154699546 | CID_154699546 | |
| 0.021 | 0.084 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.037 0.022 CID_154699546 | CID_154699546 | |
| 0.051 | 0.119 | 0.073 | Potassium channel (Tandem pore domain) blocker | 0.073 0.052 CID_154699546 | CID_154699546 | |
| 0.056 | 0.126 | 0.081 | Estrogen receptor alpha antagonist | 0.081 0.048 CID_154699546 | CID_154699546 | |
| 0.022 | 0.092 | 0.044 | Delayed rectifier potassium channel blocker | 0.044 0.017 CID_154699546 | CID_154699546 | |
| 0.033 | 0.104 | 0.047 | Cytokine production stimulant | 0.047 0.037 CID_154699546 | CID_154699546 | |
| 0.077 | 0.15 | 0.098 | TRPA1 agonist | 0.098 0.09 CID_154699546 | CID_154699546 | |
| 0.066 | 0.142 | 0.124 | Electrolyte absorption antagonist | 0.124 0.033 CID_154699546 | CID_154699546 | |
| 0.027 | 0.102 | 0.084 | 5 Hydroxytryptamine 2 agonist | 0.084 0.014 CID_154699546 | CID_154699546 | |
| 0.05 | 0.126 | 0.071 | Prolactin release inhibitor | 0.071 0.021 CID_154699546 | CID_154699546 | |
| 0.008 | 0.086 | 0.056 | Glycine transporter 1 inhibitor | 0.056 0.014 CID_154699546 | CID_154699546 | |
| 0.141 | 0.22 | 0.215 | Peptidyltransferase inhibitor | 0.215 0.082 CID_154699546 | CID_154699546 | |
| 0.04 | 0.122 | 0.056 | Pregnane X receptor antagonist | 0.056 0.041 CID_154699546 | CID_154699546 | |
| 0.024 | 0.111 | 0.069 | Protein 50S ribosomal subunit inhibitor | 0.069 0.025 CID_154699546 | CID_154699546 | |
| 0.04 | 0.128 | 0.074 | Corticotropin releasing factor 2 receptor antagonist | 0.074 0.023 CID_154699546 | CID_154699546 | |
| 0.009 | 0.098 | 0.102 | Acetylcholine M4 receptor agonist | 0.102 0.004 CID_154699546 | CID_154699546 | |
| 0.004 | 0.094 | 0.012 | Immunosuppressant Cyclosporine-like | 0.012 0.007 CID_154699546 | CID_154699546 | |
| 0.028 | 0.12 | 0.066 | Alpha-mannosidase inhibitor | 0.066 0.021 CID_154699546 | CID_154699546 | |
| 0.1 | 0.195 | 0.149 | Interferon gamma antagonist | 0.149 0.079 CID_154699546 | CID_154699546 | |
| 0.046 | 0.149 | 0.227 | Acetylcholine agonist | 0.227 0.01 CID_154699546 | CID_154699546 | |
| 0.154 | 0.261 | 0.293 | Sodium/bile acid cotransporter inhibitor | 0.293 0.085 CID_154699546 | CID_154699546 | |
| 0.025 | 0.135 | 0.064 | Histamine agonist | 0.064 0.024 CID_154699546 | CID_154699546 | |
| 0.063 | 0.173 | 0.087 | CC chemokine 5 receptor agonist | 0.087 0.043 CID_154699546 | CID_154699546 | |
| 0.026 | 0.138 | 0.045 | Aldosterone antagonist | 0.045 0.037 CID_154699546 | CID_154699546 | |
| 0.008 | 0.121 | 0.041 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.041 0.011 CID_154699546 | CID_154699546 | |
| 0.012 | 0.127 | 0.026 | Myristoyl transferase inhibitor | 0.026 0.021 CID_154699546 | CID_154699546 | |
| 0.08 | 0.195 | 0.108 | Sphingosine 1-phosphate receptor 4 antagonist | 0.108 0.099 CID_154699546 | CID_154699546 | |
| 0.014 | 0.132 | 0.07 | Cannabinoid CB2 receptor antagonist | 0.07 0.023 CID_154699546 | CID_154699546 | |
| 0.019 | 0.14 | 0.044 | AMPA 4 receptor antagonist | 0.044 0.02 CID_154699546 | CID_154699546 | |
| 0.017 | 0.141 | 0.047 | Mannosidase inhibitor | 0.047 0.029 CID_154699546 | CID_154699546 | |
| 0.012 | 0.136 | 0.038 | Cholesterol ester transfer protein antagonist | 0.038 0.015 CID_154699546 | CID_154699546 | |
| 0.083 | 0.207 | 0.367 | Sigma receptor agonist | 0.367 0.027 CID_154699546 | CID_154699546 | |
| 0.075 | 0.199 | 0.211 | Protein kinase stimulant | 0.211 0.038 CID_154699546 | CID_154699546 | |
| 0.022 | 0.149 | 0.094 | Acetylcholine M5 receptor agonist | 0.094 0.023 CID_154699546 | CID_154699546 | |
| 0.051 | 0.179 | 0.209 | Alpha 2c adrenoreceptor antagonist | 0.209 0.016 CID_154699546 | CID_154699546 | |
| 0.004 | 0.134 | 0.058 | Sigma 2 receptor antagonist | 0.058 0.008 CID_154699546 | CID_154699546 | |
| 0.032 | 0.165 | 0.057 | 5 Hydroxytryptamine 3 agonist | 0.057 0.053 CID_154699546 | CID_154699546 | |
| 0.035 | 0.17 | 0.055 | Phosphodiesterase 1A inhibitor | 0.055 0.054 CID_154699546 | CID_154699546 | |
| 0.03 | 0.166 | 0.215 | Nicotinic alpha4beta2 receptor antagonist | 0.215 0.004 CID_154699546 | CID_154699546 | |
| 0.019 | 0.158 | 0.044 | ADAM10 endopeptidase inhibitor | 0.044 0.013 CID_154699546 | CID_154699546 | |
| 0.015 | 0.156 | 0.038 | Glutamate (mGluR3) antagonist | 0.038 0.023 CID_154699546 | CID_154699546 | |
| 0.092 | 0.236 | 0.202 | Antipruritic | 0.202 0.048 CID_154699546 | CID_154699546 | |
| 0.019 | 0.165 | 0.046 | 5 Hydroxytryptamine 2B agonist | 0.046 0.017 CID_154699546 | CID_154699546 | |
| 0.125 | 0.271 | 0.238 | RNA-directed DNA polymerase inhibitor | 0.238 0.058 CID_154699546 | CID_154699546 | |
| 0.02 | 0.172 | 0.052 | GHS receptor agonist | 0.052 0.018 CID_154699546 | CID_154699546 | |
| 0.034 | 0.188 | 0.096 | Acetylcholine nicotinic agonist | 0.096 0.04 CID_154699546 | CID_154699546 | |
| 0.018 | 0.174 | 0.163 | Dopamine transporter inhibitor | 0.163 0.005 CID_154699546 | CID_154699546 | |
| 0.02 | 0.177 | 0.148 | Nicotinic receptor alpha7 subunit antagonist | 0.148 0.006 CID_154699546 | CID_154699546 | |
| 0.04 | 0.2 | 0.092 | Antihistaminic | 0.092 0.062 CID_154699546 | CID_154699546 | |
| 0.011 | 0.171 | 0.027 | 5 Hydroxytryptamine 6 agonist | 0.027 0.023 CID_154699546 | CID_154699546 | |
| 0.111 | 0.272 | 0.138 | Heat shock protein 70 antagonist | 0.138 0.085 CID_154699546 | CID_154699546 | |
| 0.006 | 0.171 | 0.052 | Endothelial nitric-oxide synthase inhibitor | 0.052 0.009 CID_154699546 | CID_154699546 | |
| 0.024 | 0.191 | 0.14 | Adrenaline uptake inhibitor | 0.14 0.01 CID_154699546 | CID_154699546 | |
| 0.096 | 0.262 | 0.176 | ATPase inhibitor | 0.176 0.063 CID_154699546 | CID_154699546 | |
| 0.032 | 0.198 | 0.083 | Histamine antagonist | 0.083 0.06 CID_154699546 | CID_154699546 | |
| 0.02 | 0.188 | 0.104 | 5 Hydroxytryptamine 2A agonist | 0.104 0.013 CID_154699546 | CID_154699546 | |
| 0.045 | 0.214 | 0.142 | Alpha 2b adrenoreceptor antagonist | 0.142 0.043 CID_154699546 | CID_154699546 | |
| 0.031 | 0.211 | 0.074 | 5 Hydroxytryptamine 5A antagonist | 0.074 0.027 CID_154699546 | CID_154699546 | |
| 0.006 | 0.187 | 0.033 | Nicotinic alpha3beta4 receptor agonist | 0.033 0.017 CID_154699546 | CID_154699546 | |
| 0.021 | 0.203 | 0.082 | Calcium channel T-type blocker | 0.082 0.021 CID_154699546 | CID_154699546 | |
| 0.006 | 0.19 | 0.035 | Imidazoline I1 receptor antagonist | 0.035 0.005 CID_154699546 | CID_154699546 | |
| 0.023 | 0.207 | 0.114 | Dopamine D1 antagonist | 0.114 0.021 CID_154699546 | CID_154699546 | |
| 0.008 | 0.193 | 0.021 | Motilin receptor agonist | 0.021 0.019 CID_154699546 | CID_154699546 | |
| 0.02 | 0.206 | 0.067 | Benzodiazepine agonist | 0.067 0.055 CID_154699546 | CID_154699546 | |
| 0.045 | 0.232 | 0.069 | MDM2 inhibitor | 0.069 0.042 CID_154699546 | CID_154699546 | |
| 0.011 | 0.198 | 0.234 | Acetylcholine muscarinic agonist | 0.234 0.005 CID_154699546 | CID_154699546 | |
| 0.044 | 0.234 | 0.098 | Bile acid receptor antagonist | 0.098 0.054 CID_154699546 | CID_154699546 | |
| 0.026 | 0.219 | 0.101 | Androgen antagonist | 0.101 0.046 CID_154699546 | CID_154699546 | |
| 0.016 | 0.214 | 0.051 | Nicotinic neuronal receptor agonist | 0.051 0.045 CID_154699546 | CID_154699546 | |
| 0.136 | 0.337 | 0.363 | Interleukin 2 agonist | 0.363 0.04 CID_154699546 | CID_154699546 | |
| 0.015 | 0.218 | 0.085 | 5 Hydroxytryptamine 6 antagonist | 0.085 0.02 CID_154699546 | CID_154699546 | |
| 0.026 | 0.231 | 0.065 | 5 Hydroxytryptamine 5 antagonist | 0.065 0.03 CID_154699546 | CID_154699546 | |
| 0.011 | 0.217 | 0.071 | NMDA 2C receptor antagonist | 0.071 0.032 CID_154699546 | CID_154699546 | |
| 0.029 | 0.237 | 0.175 | Alpha 2 adrenoreceptor antagonist | 0.175 0.022 CID_154699546 | CID_154699546 | |
| 0.004 | 0.214 | 0.028 | Sigma 1 receptor antagonist | 0.028 0.018 CID_154699546 | CID_154699546 | |
| 0.02 | 0.232 | 0.05 | Histamine H4 receptor antagonist | 0.05 0.031 CID_154699546 | CID_154699546 | |
| 0.065 | 0.277 | 0.104 | Transcription factor STAT6 inhibitor | 0.104 0.096 CID_154699546 | CID_154699546 | |
| 0.148 | 0.364 | 0.247 | Cyclophilin D inhibitor | 0.247 0.217 CID_154699546 | CID_154699546 | |
| 0.06 | 0.277 | 0.117 | Cell wall synthesis inhibitor | 0.117 0.105 CID_154699546 | CID_154699546 | |
| 0.006 | 0.226 | 0.216 | Acetylcholine M1 receptor agonist | 0.216 0.004 CID_154699546 | CID_154699546 | |
| 0.137 | 0.358 | 0.288 | Ca(v)3.3 blocker | 0.288 0.054 CID_154699546 | CID_154699546 | |
| 0.009 | 0.24 | 0.064 | Cannabinoid CB1 receptor agonist | 0.064 0.04 CID_154699546 | CID_154699546 | |
| 0.018 | 0.251 | 0.082 | Protein kinase C beta inhibitor | 0.082 0.027 CID_154699546 | CID_154699546 | |
| 0.035 | 0.272 | 0.118 | Nitric-oxide synthase inhibitor | 0.118 0.039 CID_154699546 | CID_154699546 | |
| 0.023 | 0.265 | 0.111 | Alpha 2a adrenoreceptor antagonist | 0.111 0.032 CID_154699546 | CID_154699546 | |
| 0.004 | 0.257 | 0.031 | Progesterone antagonist | 0.031 0.028 CID_154699546 | CID_154699546 | |
| 0.026 | 0.28 | 0.148 | Acetylcholine M3 receptor agonist | 0.148 0.021 CID_154699546 | CID_154699546 | |
| 0.012 | 0.272 | 0.094 | 5 Hydroxytryptamine 1F antagonist | 0.094 0.034 CID_154699546 | CID_154699546 | |
| 0.013 | 0.277 | 0.052 | Cyclin-dependent kinase 6 inhibitor | 0.052 0.051 CID_154699546 | CID_154699546 | |
| 0.017 | 0.282 | 0.083 | Cannabinoid receptor antagonist | 0.083 0.038 CID_154699546 | CID_154699546 | |
| 0.033 | 0.301 | 0.119 | 5 Hydroxytryptamine 3A agonist | 0.119 0.057 CID_154699546 | CID_154699546 | |
| 0.013 | 0.281 | 0.074 | TRPA1 antagonist | 0.074 0.03 CID_154699546 | CID_154699546 | |
| 0.013 | 0.284 | 0.065 | 5 Hydroxytryptamine 1D antagonist | 0.065 0.043 CID_154699546 | CID_154699546 | |
| 0.019 | 0.295 | 0.126 | Alpha adrenoreceptor antagonist | 0.126 0.045 CID_154699546 | CID_154699546 | |
| 0.012 | 0.29 | 0.062 | 5 Hydroxytryptamine 1B antagonist | 0.062 0.048 CID_154699546 | CID_154699546 | |
| 0.07 | 0.353 | 0.318 | Cardiotonic | 0.318 0.049 CID_154699546 | CID_154699546 | |
| 0.021 | 0.306 | 0.109 | Inducible nitric-oxide synthase inhibitor | 0.109 0.03 CID_154699546 | CID_154699546 | |
| 0.013 | 0.299 | 0.025 | Toll-Like receptor 4 agonist | 0.025 0.024 CID_154699546 | CID_154699546 | |
| 0.043 | 0.339 | 0.158 | Cholinergic | 0.158 0.07 CID_154699546 | CID_154699546 | |
| 0.011 | 0.308 | 0.08 | Dopamine D3 antagonist | 0.08 0.033 CID_154699546 | CID_154699546 | |
| 0.004 | 0.314 | 0.036 | Farnesoid X receptor agonist | 0.036 0.028 CID_154699546 | CID_154699546 | |
| 0.015 | 0.327 | 0.066 | Cannabinoid CB1 receptor antagonist | 0.066 0.038 CID_154699546 | CID_154699546 | |
| 0.007 | 0.321 | 0.057 | Opioid kappa receptor agonist | 0.057 0.02 CID_154699546 | CID_154699546 | |
| 0.022 | 0.34 | 0.05 | Glucosylceramidase inhibitor | 0.05 0.047 CID_154699546 | CID_154699546 | |
| 0.01 | 0.331 | 0.059 | Acetylcholine M2 receptor agonist | 0.059 0.03 CID_154699546 | CID_154699546 | |
| 0.004 | 0.33 | 0.031 | HCV NS5A inhibitor | 0.031 0.013 CID_154699546 | CID_154699546 | |
| 0.047 | 0.377 | 0.121 | Neuropeptide Y1 antagonist | 0.121 0.12 CID_154699546 | CID_154699546 | |
| 0.011 | 0.344 | 0.048 | Potassium channel (Inward rectifier) blocker | 0.048 0.037 CID_154699546 | CID_154699546 | |
| 0.004 | 0.345 | 0.037 | Vascular adhesion protein 1 inhibitor | 0.037 0.029 CID_154699546 | CID_154699546 | |
| 0.009 | 0.351 | 0.101 | 5 Hydroxytryptamine 3 antagonist | 0.101 0.017 CID_154699546 | CID_154699546 | |
| 0.029 | 0.378 | 0.107 | Antineoplastic alkaloid | 0.107 0.044 CID_154699546 | CID_154699546 | |
| 0.041 | 0.393 | 0.483 | Anticonvulsant | 0.483 0.013 CID_154699546 | CID_154699546 | |
| 0.006 | 0.363 | 0.066 | Alpha 1a adrenoreceptor antagonist | 0.066 0.053 CID_154699546 | CID_154699546 | |
| 0.007 | 0.366 | 0.164 | 5 Hydroxytryptamine uptake inhibitor | 0.164 0.014 CID_154699546 | CID_154699546 | |
| 0.063 | 0.423 | 0.401 | Immunosuppressant | 0.401 0.062 CID_154699546 | CID_154699546 | |
| 0.009 | 0.374 | 0.029 | Cyclophilin A inhibitor | 0.029 0.025 CID_154699546 | CID_154699546 | |
| 0.031 | 0.41 | 0.09 | Bromodomain-containing protein 2 inhibitor | 0.09 0.056 CID_154699546 | CID_154699546 | |
| 0.006 | 0.386 | 0.034 | 5 Hydroxytryptamine 1F agonist | 0.034 0.01 CID_154699546 | CID_154699546 | |
| 0.022 | 0.403 | 0.12 | Toll-Like receptor 9 antagonist | 0.12 0.086 CID_154699546 | CID_154699546 | |
| 0.017 | 0.401 | 0.063 | Orexin receptor antagonist | 0.063 0.052 CID_154699546 | CID_154699546 | |
| 0.005 | 0.393 | 0.018 | Progesterone receptor B antagonist | 0.018 0.017 CID_154699546 | CID_154699546 | |
| 0.013 | 0.405 | 0.138 | 5 Hydroxytryptamine antagonist | 0.138 0.055 CID_154699546 | CID_154699546 | |
| 0.005 | 0.405 | 0.124 | Dopamine D2 antagonist | 0.124 0.027 CID_154699546 | CID_154699546 | |
| 0.024 | 0.432 | 0.128 | Cytidine deaminase inhibitor | 0.128 0.093 CID_154699546 | CID_154699546 | |
| 0.006 | 0.426 | 0.104 | Nicotinic receptor alpha4 subunit antagonist | 0.104 0.007 CID_154699546 | CID_154699546 | |
| 0.007 | 0.436 | 0.161 | Dopamine antagonist | 0.161 0.024 CID_154699546 | CID_154699546 | |
| 0.016 | 0.449 | 0.073 | Orexin receptor 1 antagonist | 0.073 0.047 CID_154699546 | CID_154699546 | |
| 0.016 | 0.471 | 0.082 | Polo-like kinase-1 inhibitor | 0.082 0.079 CID_154699546 | CID_154699546 | |
| 0.001 | 0.463 | 0.014 | Calcineurin inhibitor | 0.014 0.005 CID_154699546 | CID_154699546 | |
| 0.034 | 0.499 | 0.207 | Non-steroidal antiinflammatory agent | 0.207 0.066 CID_154699546 | CID_154699546 | |
| 0.005 | 0.482 | 0.068 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.068 0.019 CID_154699546 | CID_154699546 | |
| 0.045 | 0.536 | 0.205 | Hypoxia-inducible factor 1 alpha inhibitor | 0.205 0.146 CID_154699546 | CID_154699546 | |
| 0.047 | 0.566 | 0.281 | Antibacterial | 0.281 0.15 CID_154699546 | CID_154699546 | |
| 0.022 | 0.555 | 0.115 | Activin receptor-like kinase 2 inhibitor | 0.115 0.102 CID_154699546 | CID_154699546 | |
| 0.022 | 0.622 | 0.124 | Hemostatic | 0.124 0.107 CID_154699546 | CID_154699546 | |
| 0.016 | 0.625 | 0.078 | Polo-like kinase-2 inhibitor | 0.078 0.046 CID_154699546 | CID_154699546 | |
| 0.016 | 0.706 | 0.098 | Alpha 2d adrenoreceptor antagonist | 0.098 0.052 CID_154699546 | CID_154699546 | |
| 0.003 | 0.718 | 0.052 | CXC chemokine 3 receptor antagonist | 0.052 0.009 CID_154699546 | CID_154699546 | |
| 0.005 | 0.729 | 0.124 | CXC chemokine receptor antagonist | 0.124 0.016 CID_154699546 | CID_154699546 | |
| 0.021 | 0.776 | 0.088 | T cell inhibitor | 0.088 0.041 CID_154699546 | CID_154699546 | |
| 0.003 | 0.821 | 0.046 | Dopamine D4 agonist | 0.046 0.041 CID_154699546 | CID_154699546 | |
| 0.011 | 0.834 | 0.078 | Phosphodiesterase VIII inhibitor | 0.078 0.038 CID_154699546 | CID_154699546 | |
| 0.003 | 0.881 | 0.053 | Bromodomain-containing protein 4 inhibitor | 0.053 0.041 CID_154699546 | CID_154699546 | |
| 0.005 | 0.894 | 0.661 | Antiobesity | 0.661 0.014 CID_154699546 | CID_154699546 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |